{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:21:58Z","timestamp":1782267718569,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009389","name":"Stiftelsen Promobilia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jns.2025.123439","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T02:35:25Z","timestamp":1740710125000},"page":"123439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barr\u00e9 syndrome \u2013 clinical utilization and a new insight into pathophysiological mechanisms"],"prefix":"10.1016","volume":"472","author":[{"given":"Ivan","family":"Kmezic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayomand","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.jns.2025.123439_bb0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2025.123439_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barre syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.jns.2025.123439_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/practneurol-2014-000937","article-title":"Mimics and chameleons in Guillain-Barre and Miller Fisher syndromes","volume":"15","author":"Wakerley","year":"2015","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2025.123439_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jns.12594","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"28","author":"Van Doorn","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.jns.2025.123439_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jns.2025.123439_bb0035","series-title":"The CSF Proteins: A Biochemical Approach","author":"Thompson","year":"2005"},{"key":"10.1016\/j.jns.2025.123439_bb0040","first-page":"91","article-title":"Proteins in normal cerebrospinal fluid not found in serum","volume":"109","author":"Clausen","year":"1961","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"6 Pt 1","key":"10.1016\/j.jns.2025.123439_bb0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/clinchem\/48.6.939","article-title":"beta-Trace protein as a marker for cerebrospinal fluid rhinorrhea","volume":"48","author":"Arrer","year":"2002","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123439_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cccn.2004.09.008","article-title":"Rapid, accurate and non-invasive detection of cerebrospinal fluid leakage using combined determination of beta-trace protein in secretion and serum","volume":"351","author":"Risch","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.jns.2025.123439_bb0055","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2014.06.038","article-title":"\u03b2-Trace protein: a marker of GFR and other biological pathways","volume":"65","author":"White","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.1993.tb02145.x","article-title":"Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase","volume":"61","author":"Hoffmann","year":"1993","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(96)12614-8","article-title":"Choroid plexus: the major site of mRNA expression for the beta-trace protein (prostaglandin D synthase) in human brain","volume":"209","author":"Bl\u00f6dorn","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.jns.2025.123439_bb0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<730::AID-JNR14>3.0.CO;2-7","article-title":"Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry","volume":"57","author":"Bl\u00f6dorn","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3340\/jkns.2015.57.4.235","article-title":"Correlation of the Beta-trace protein and inflammatory cytokines with magnetic resonance imaging in chronic subdural hematomas: a prospective study","volume":"57","author":"Park","year":"2015","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0090-6980(97)00062-2","article-title":"Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders","volume":"54","author":"Melegos","year":"1997","journal-title":"Prostaglandins."},{"issue":"12","key":"10.1016\/j.jns.2025.123439_bb0090","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/clinchem\/42.12.1984","article-title":"Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids","volume":"42","author":"Melegos","year":"1996","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/glycob\/7.4.499","article-title":"Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases","volume":"7","author":"Hoffmann","year":"1997","journal-title":"Glycobiology."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1750-3639.1992.tb00703.x","article-title":"Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance","volume":"2","author":"Cserr","year":"1992","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.jns.2025.123439_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2008.03.006","article-title":"Pharmacokinetics of recombinant human lipocalin-type prostaglandin D synthase\/beta-trace in canine","volume":"61","author":"Li","year":"2008","journal-title":"Neurosci. Res."},{"issue":"6","key":"10.1016\/j.jns.2025.123439_bb0110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.410440606","article-title":"Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases","volume":"44","author":"Tumani","year":"1998","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1515\/cclm-2016-0442","article-title":"Retrospective validation of a \u03b2-trace protein interpretation algorithm for the diagnosis of cerebrospinal fluid leakage","volume":"55","author":"Bernasconi","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.jns.2025.123439_bb0120","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"8093","key":"10.1016\/j.jns.2025.123439_bb0130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","article-title":"A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation","volume":"10","author":"Gaetani","year":"2018","journal-title":"Alzheimers Res. Ther."},{"issue":"9","key":"10.1016\/j.jns.2025.123439_bb0145","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1007\/s00415-021-10479-9","article-title":"Cerebrospinal fluid analysis in Guillain\u2013Barr\u00e9 syndrome: value of albumin quotients","volume":"268","author":"Rath","year":"2021","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123439_bb0150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025348","article-title":"Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care center","volume":"9","author":"Brooks","year":"2019","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jns.2025.123439_bb0160","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","article-title":"Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force","volume":"13","author":"Deisenhammer","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"Pt 8","key":"10.1016\/j.jns.2025.123439_bb0165","article-title":"Blood-cerebrospinal fluid barrier dysfunction in patients with neurological symptoms during the 2011 Northern German E. coli serotype O104:H4 outbreak","volume":"136","author":"Skripuletz","year":"2013","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jns.12253","article-title":"Cerebrospinal fluid total protein determination in acute and chronic inflammatory demyelinating polyneuropathies: a critical reappraisal","volume":"23","author":"Franciotta","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"14","key":"10.1016\/j.jns.2025.123439_bb0175","doi-asserted-by":"crossref","first-page":"1330484","DOI":"10.3389\/fneur.2023.1330484","article-title":"Comparative analysis of albumin quotient and total CSF protein in immune-mediated neuropathies: a multicenter study on diagnostic implications","author":"Seeliger","year":"2024","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mus.26488","article-title":"Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosis","volume":"60","author":"Breiner","year":"2019","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.jns.2025.123439_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.26513","article-title":"Does cerebrospinal fluid analysis have a meaningful role in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy?","volume":"60","author":"London","year":"2019","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.jns.2025.123439_bb0190","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2025.123439_bb0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jns.2018.12.036","article-title":"Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy","volume":"397","author":"Lucke","year":"2019","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2025.123439_bb0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1471-4159.1973.tb00043.x","article-title":"Distribution of serum proteins and beta-trace protein within the nervous system","volume":"20","author":"Olsson","year":"1973","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.jns.2025.123439_bb0205","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1471-4159.1973.tb07570.x","article-title":"Metabolic studies on 125I-labelled beta-trace protein, with special reference to synthesis within the central nervous system","volume":"21","author":"Olsson","year":"1973","journal-title":"J. Neurochem."},{"issue":"26","key":"10.1016\/j.jns.2025.123439_bb0210","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1073\/pnas.94.26.14689","article-title":"Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients","volume":"94","author":"Eguchi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2 Pt 2","key":"10.1016\/j.jns.2025.123439_bb0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/hy0202.102835","article-title":"Lipocalin-type prostaglandin d synthase in essential hypertension","volume":"39","author":"Hirawa","year":"2002","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/glia.23705","article-title":"Prostaglandin D2 synthase modulates macrophage activity and accumulation in injured peripheral nerves","volume":"68","author":"Forese","year":"2020","journal-title":"Glia."},{"issue":"25","key":"10.1016\/j.jns.2025.123439_bb0225","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.272.25.15789","article-title":"Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter","volume":"272","author":"Tanaka","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.jns.2025.123439_bb0230","doi-asserted-by":"crossref","first-page":"8006","DOI":"10.1021\/bi990261p","article-title":"Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase","volume":"38","author":"Beuckmann","year":"1999","journal-title":"Biochemistry."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123439_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0167-4838(00)00161-8","article-title":"Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase","volume":"1482","author":"Urade","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.jns.2025.123439_bb0240","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1346-8138.2011.01485.x","article-title":"Lipocalin-type prostaglandin D synthase as a marker for the proliferative potential of melanocyte-lineage cells in the human skin","volume":"39","author":"Shimanuki","year":"2012","journal-title":"J. Dermatol."},{"issue":"126","key":"10.1016\/j.jns.2025.123439_bb0245","doi-asserted-by":"crossref","first-page":"126ra34","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jns.2025.123439_bb0250","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1359\/JBMR.041211","article-title":"Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors","volume":"20","author":"Gallant","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.jns.2025.123439_bb0255","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jns.2025.123439_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/503128","article-title":"PGD synthase and PGD2 in immune response","volume":"2012","author":"Joo","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.jns.2025.123439_bb0265","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1292\/jvms.16-0347","article-title":"Discovery of anti-inflammatory role of prostaglandin D2","volume":"78","author":"Murata","year":"2016","journal-title":"J. Vet. Med. Sci."},{"issue":"12","key":"10.1016\/j.jns.2025.123439_bb0270","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nn.3857","article-title":"Prostaglandin D2 synthase\/GPR44: a signaling axis in PNS myelination","volume":"17","author":"Trimarco","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2025.123439_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3344\/kjp.2021.34.1.27","article-title":"Prostaglandin D2 contributes to cisplatin-induced neuropathic pain in rats via DP2 receptor in the spinal cord","volume":"34","author":"Li","year":"2021","journal-title":"Korean J. Pain."},{"key":"10.1016\/j.jns.2025.123439_bb0280","doi-asserted-by":"crossref","first-page":"ec350","DOI":"10.1126\/scisignal.aaa4770","article-title":"Prostaglandin promotes myelination","volume":"7","author":"Ferrarelli","year":"2014","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.jns.2025.123439_bb0285","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","article-title":"Prostaglandin D2 mediates neuronal protection via the DP1 receptor","volume":"92","author":"Liang","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2025.123439_bb0290","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/168953","article-title":"Arachidonic acid derivatives and their role in peripheral nerve degeneration and regeneration","volume":"2012","author":"Camara-Lemarroy","year":"2012","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.jns.2025.123439_bb0295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2017.00038","article-title":"Molecular mechanisms involved in Schwann cell plasticity","volume":"10","author":"Boerboom","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2025.123439_bb0300","article-title":"Prostaglandin D2 synthase controls Schwann cells metabolism","author":"Trimarco","year":"2024","journal-title":"bioRxiv"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:51:18Z","timestamp":1762210278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"alternative-id":["S0022510X25000565"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123439","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-trace protein in chronic inflammatory demyelinating polyradiculoneuropathy and Guillain-Barr\u00e9 syndrome \u2013 clinical utilization and a new insight into pathophysiological mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123439"}}